• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Yotsumoto Fusanori  四元 房典

ORCIDConnect your ORCID iD *help
… Alternative Names

四元 房典  ヨツモト フサノリ

YOTSUMOTO Fusanori  四元 房典

Less
Researcher Number 40533089
Other IDs
Affiliation (Current) 2025: 福岡大学, 医学部, 教授
Affiliation (based on the past Project Information) *help 2025: 福岡大学, 医学部, 教授
2019 – 2020: 福岡大学, 医学部, 准教授
2018: 福岡大学, 医学部, 講師
2016: 福岡大学, 医学部, 講師
2014: 福岡大学, 医学部, 講師
2010 – 2011: 福岡大学, 医学部, 講師
Review Section/Research Field
Principal Investigator
Basic Section 56040:Obstetrics and gynecology-related / Laboratory medicine
Except Principal Investigator
Basic Section 56040:Obstetrics and gynecology-related / Obstetrics and gynecology
Keywords
Principal Investigator
腫瘍検査学 / 乳癌 / HB-EGF
Except Principal Investigator
microRNA / 卵巣癌 / micro RNA / DDS / ウルトラファインバブル / 核酸医薬 / 診断マイクロアレイ … More / マイクロRNA / microRNA array / miR-135a-3p / miRNA / BK-UM / HB-EGF / バイオマーカー Less
  • Research Projects

    (4 results)
  • Research Products

    (26 results)
  • Co-Researchers

    (7 People)
  •  統合転写プロファイルとマルチモーダルAI分析を用いたEAOC予測診断システムの構築Principal Investigator

    • Principal Investigator
      四元 房典
    • Project Period (FY)
      2025 – 2027
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Fukuoka University
  •  Development of nucleic acid drug for intractable ovarian cancer using drug delivery system(DDS) by ultra fine bubble

    • Principal Investigator
      Miyamoto Shingo
    • Project Period (FY)
      2018 – 2020
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Fukuoka University
  •  Searching gene to manufacture the companion diagnostic agent targeting the HB-EGF.

    • Principal Investigator
      Miyamoto Shingo
    • Project Period (FY)
      2014 – 2016
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Fukuoka University
  •  Application for genes involved in regulation of HB-EGF expression as diagnostic markers and target molecules for breast cancerPrincipal Investigator

    • Principal Investigator
      YOTSUMOTO Fusanori
    • Project Period (FY)
      2010 – 2011
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Laboratory medicine
    • Research Institution
      Fukuoka University

All 2018 2017 2015 2014 2011 2010 Other

All Journal Article Presentation

  • [Journal Article] BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: a first-in-human phase-I study.2017

    • Author(s)
      Miyamoto S, Yotsumoto F,他30名、 Iwamoto R, Mekada E.
    • Journal Title

      BMC Cancer.

      Volume: 17 Issue: 1 Pages: 89-97

    • DOI

      10.1186/s12885-017-3071-5

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26250033, KAKENHI-PROJECT-26293362, KAKENHI-PROJECT-15K07046
  • [Journal Article] Pre-clinical study of BK-UM, a novel inhibitor of HB-EGF, for ovarian cancer therapy.2014

    • Author(s)
      Nam SO, Yotsumoto F, Miyata K, Suzaki Y, Yagi H, Odawara T, Manabe S, Ishikawa T, Kuroki M, Mekada E, Miyamoto S
    • Journal Title

      Anticancer Research

      Volume: 34 Pages: 4615-4620

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-26293362
  • [Journal Article] Contribution of transcription factor, SP1, to the promotion of HB-EGF expression in defense mechanism against the treatment of irinotecan in ovarian clear cell carcinoma.2014

    • Author(s)
      Miyata K, Yotsumoto F, Nam SO, Odawara T, Manabe S, Ishikawa T, Itamochi H, Kigawa J, Takada S, Asahara H, Kuroki M, Miyamoto S
    • Journal Title

      Cancer Medicine

      Volume: 3 Issue: 5 Pages: 1159-1169

    • DOI

      10.1002/cam4.301

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-26293362, KAKENHI-PROJECT-26670731
  • [Journal Article] Proteolytic activation of heparin-binding EGF-like growth factor by membrane-type matrix metalloproteinase-1 in ovarian carcinoma cells2011

    • Author(s)
      Koshikawa N, Mizushima H, Minegishi T, Eguchi F, Yotsumoto F, Nabeshima K, Miyamoto S, Mekada E, Seiki M
    • Journal Title

      Cancer Science

      Volume: Vol.102 Pages: 111-116

    • NAID

      10029288679

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22790536
  • [Journal Article] A Novel Anti-Human HB-EGF Monoclonal Antibody with Multiple Anti-Tumor Mechanisms Against Ovarian Cancer Cells2011

    • Author(s)
      Miyamoto S, Iwamoto R, Furuya A, Takahashi K, Sasaki Y, Ando H, Yotsumoto F, Yoneda T, Hamaoka M, Yagi H, Murakami T, Hori S, Shitara K, Mekada E
    • Journal Title

      Clinical Cancer Research

      Volume: Vol.17 Pages: 6733-6741

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22790536
  • [Journal Article] Antitumor effects of CRM197, a specific inhibitor of HB-EGF, in T-cell acute lymphoblastic leukemia2011

    • Author(s)
      Kunami N, Yotsumoto F, Ishitsuka K, Fukami T, Odawara T, Manabe S, Ishikawa T, Tamura K, Kuroki M, Miyamoto S
    • Journal Title

      Anticancer Research

      Volume: Vol.31 Pages: 2483-2488

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22790536
  • [Journal Article] A possible clinical adaptation of CRM197 in combination with conventional chemotherapeutic agents for ovarian cancer2011

    • Author(s)
      Tsujioka H, Fukami T, Yotsumoto F, Ueda T, Hikita S, Takahashi Y, Kondo H, Kuroki M, Miyamoto S
    • Journal Title

      Anticancer Research

      Volume: Vol.31 Pages: 2461-2465

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22790536
  • [Journal Article] Assessment of HB-EGF levels in peritoneal fluid and serum of ovarian cancer patients using ELISA2011

    • Author(s)
      Hikita S, Yotsumoto F, Fukami T, Horiuchi S, Sanui A, Miyata K, Nam S, Tsujioka H, Ueda T, Shirota K, Yoshizato T, Maeda K, Ishikawa T, Okuno Y, Kuroki M, Mekada E, Miyamoto S
    • Journal Title

      Anticancer Research

      Volume: 31 Pages: 2553-2559

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22790536
  • [Journal Article] Assessment of HB-EGF levels in peritoneal fluid and serum of ovarian cancer patients using ELISA2011

    • Author(s)
      Hikita S, Yotsumoto F, Fukami T, Horiuchi S, Sanui A, Miyata K, Nam SO, Tsujioka H, Ueda T, Shirota K, Yoshizato T, Maeda K, Ishikawa T, Okuno Y, Kuroki M, Mekada E, Miyamoto S
    • Journal Title

      Anticancer Research

      Volume: Vol.31 Pages: 2553-2559

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22790536
  • [Journal Article] HB-EGF orchestrates the complex signals involved in triple-negative and trastuzumab-resistant breast cancer2010

    • Author(s)
      Yotsumoto F, Oki E, Tokunaga E, Maehara Y, Kuroki M, Miyamoto S
    • Journal Title

      International Journal of Cancer

      Volume: Vol.127 Pages: 2707-2717

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22790536
  • [Journal Article] Apoptosis as a possiblecandidate mechanism for removal of tamoxifen-related endometrial cells with KRAS mutations2010

    • Author(s)
      Tsujioka H, Hachisuga T, Hikita S, Ueda T, Yotsumoto F, Shirota K, Yoshizato T, Kawarabayashi T, Kuroki M, Miyamoto S
    • Journal Title

      Anticancer Research

      Volume: Vol.30 Pages: 3119-3123

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22790536
  • [Journal Article] Emerging strategies for ErbB ligand-based targeted therapy for cancer2010

    • Author(s)
      Tsujioka H, Yotsumoto F, Shirota K, Horiuchi S, Yoshizato T, Kuroki M, Miyamoto S
    • Journal Title

      Anticancer Research

      Volume: Vol.30 Pages: 3107-3112

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22790536
  • [Journal Article] Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer2010

    • Author(s)
      Yotsumoto F, Fukami T, Yagi H, Funakoshi A, Yoshizato T, Kuroki M, Miyamoto S
    • Journal Title

      Cancer Science

      Volume: Vol.101 Pages: 2351-2360

    • NAID

      10027833378

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22790536
  • [Journal Article] Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer.2010

    • Author(s)
      Yotsumoto F, Fukami T, Yagi H, Funakoshi A, Yoshizato T, Kuroki M, Miyamoto S.
    • Journal Title

      Cancer Science

      Volume: 101 Pages: 2351-2360

    • NAID

      10027833378

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22790536
  • [Journal Article] HB-EGF orchestrates the complex signals involved in triple-negative and trastuzumab-resistant breast cancer.2010

    • Author(s)
      Yotsumoto F, Oki E, Tokunaga E, Maehara Y, Kuroki M, Miyamoto S.
    • Journal Title

      International Journal of Cancer

      Volume: 127 Pages: 2707-2717

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22790536
  • [Journal Article] HB-EGF inhibition in combination with various anticancer agents enhances its antitumor effects in gastric cancer2010

    • Author(s)
      Sanui A, Yotsumoto F, Tsujioka H, Fukami T, Horiuchi S, Shirota K, Yoshizato T, Kawarabayashi T, Kuroki M, Miyamoto S
    • Journal Title

      Anticancer Research

      Volume: Vol.30 Pages: 3143-3149

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22790536
  • [Journal Article] HB-EGF inhibition in combination with various anticancer agents enhances its antitumor effects in gastric cancer.2010

    • Author(s)
      Sanui A, Yotsumoto F, Tsujioka H, Fukami T, Horiuchi S, Shirota K, Yoshizato T, Kawarabayashi T, Kuroki M, Miyamoto S.
    • Journal Title

      Anticancer Research

      Volume: 30 Pages: 3143-3149

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22790536
  • [Journal Article] Apoptosis as a possible candidate mechanism for removal of tamoxifen-related endometrial cells with KRAS mutations.2010

    • Author(s)
      Tsujioka H, Hachisuga T, Hikita S, Ueda T, Yotsumoto F, Shirota K, Yoshizato T, Kawarabayashi T, Kuroki M, Miyamoto S.
    • Journal Title

      Anticancer Research

      Volume: 30 Pages: 3119-3123

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22790536
  • [Journal Article] Emerging strategies for ErbB ligand-based targeted therapy for cancer.2010

    • Author(s)
      Tsujioka H, Yotsumoto F, Shirota K, Horiuchi S, Yoshizato T, Kuroki M, Miyamoto S.
    • Journal Title

      Anticancer Research

      Volume: 30 Pages: 3107-3112

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22790536
  • [Presentation] 再発卵巣癌の予後予測バイオマーカーとしての血中HB-EGFの有用性2018

    • Author(s)
      深川怜史、井槌大介、勝田隆博、南 星旭、四元房典、宮原大輔、城田京子、宮本新吾
    • Organizer
      日本産科婦人科学会第70回学術講演会
    • Data Source
      KAKENHI-PROJECT-18K09242
  • [Presentation] 卵巣癌予後予測因子としての microRNA の解析2015

    • Author(s)
      深川怜史、宮田康平、四元房典、黒木政秀、安永晋一郎、宮本新吾
    • Organizer
      日本癌学会
    • Place of Presentation
      (名古屋)名古屋国際会議場
    • Year and Date
      2015-10-08
    • Data Source
      KAKENHI-PROJECT-26293362
  • [Presentation] 卵巣癌における予後予測および薬剤感受性に関わるmicroRNA2015

    • Author(s)
      四元房典、深川怜史、宮田康平、南 星旭、安永晋一郎、黒木政秀、宮本新吾
    • Organizer
      第14回日本婦人科がん分子標的研究会学術集会
    • Place of Presentation
      (松本) 美ケ原温泉ホテル翔峰
    • Year and Date
      2015-07-18
    • Data Source
      KAKENHI-PROJECT-26293362
  • [Presentation] 卵巣癌予後予測因子としてのmicroRNAの検索2015

    • Author(s)
      深川怜史、宮田康平、南星旭、四元房典、宮本新吾
    • Organizer
      第67回日本産婦人科学会学術集会
    • Place of Presentation
      (横浜)パシフィコ横浜
    • Year and Date
      2015-04-09
    • Data Source
      KAKENHI-PROJECT-26293362
  • [Presentation] 癌治療標的分子HB-EGFの翻訳制御にかかわる分子の同定2014

    • Author(s)
      宮田康平、四元房典、深川怜史、南星旭、黒木政秀、宮本新吾
    • Organizer
      第18回バイオ治療法研究会学術集会
    • Place of Presentation
      高松
    • Year and Date
      2014-12-13
    • Data Source
      KAKENHI-PROJECT-26293362
  • [Presentation] Antitumor effect of intravenous injection of an HB-EGF inhibitor, CRM197, in triple negative breast cancer

    • Author(s)
      Satoshi Fukagawa, Sung Ouk Nam, Fusanori Yotsumoto, Kohei Miyata, Masahide Kuroki, Shingo Miyamoto
    • Organizer
      第73回日本癌学会学術総会
    • Place of Presentation
      横浜
    • Year and Date
      2014-09-25 – 2014-09-27
    • Data Source
      KAKENHI-PROJECT-26293362
  • [Presentation] Regulation of HB-EGF expression via a translational regulator, RBM8A.

    • Author(s)
      Miyata K, Yotsumoto F, Nam SO, Fukagawa S, Kuroki M, Miyamoto S
    • Organizer
      第73回日本癌学会学術総会
    • Place of Presentation
      横浜
    • Year and Date
      2014-09-25 – 2014-09-27
    • Data Source
      KAKENHI-PROJECT-26293362
  • 1.  Miyamoto Shingo (40209945)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 9 results
  • 2.  深川 怜史 (20772453)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 7 results
  • 3.  鍋島 一樹 (40189189)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 4.  八木 裕史 (70623552)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 5.  立花 克郎 (40271605)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 6.  目加田 英輔
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 7.  岩本 亮
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi